Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey


escrs app advert

Comparison of clinical outcomes after implantation of trifocal lenses with same optic but different material (hydrophobic and hydrophilic) in the same patient

Search Title by author or title

Session Details

Session Title: Multifocal IOLs

Session Date/Time: Sunday 23/09/2018 | 16:30-18:00

Paper Time: 17:27

Venue: Room A3, Podium 1

First Author: : Z.Nagy HUNGARY

Co Author(s): :    H. Kiss                    

Abstract Details


The purpose of this clinical study is to compare the clinical outcomes of two trifocal non-toric IOLs, the POD F and POD F GF (both PhysIOL, Liège, Belgium) having the same optical parameters but differing in the IOL material (hydrophilic vs. hydrophobic).


Semmelweis University - Department of Ophthalmology, Budapest, Hungary Prospective, Single-center, Comparative


Subjects with cataractous eyes and regular corneal astigmatism <0.75D underwent bilateral refractive lens exchange with trifocal intraocular lenses, with one eye implanted with the hydrophilic POD F and the contralateral eye with the hydrophobic POD F GF IOL (both PhysIOL, Liège, Belgium). Preoperative manifest refraction, photopic and mesopic visual acuity (far, intermediate, near), and contrast sensitivity were compared with follow-up at 1, 3, and 6 months. Safety was monitored through adverse event reporting.


Fifty eyes of 25 patients (15 F) with mean age 58.8 ± 7.8 years were included. Both IOLs achieved refractive outcomes close to emmetropia across all follow-up visits (p<0.05). Significant improvements were observed in far, intermediate, and near vision at 6-month follow-up for both lenses. No significant differences were noted in defocus curves or contrast sensitivity. No adverse events were recorded.


Implantation of the POD F and POD F GF intraocular lenses allows for a safe and efficient restoration of near, intermediate, and far visual acuity on patients undergoing IOL implantation.

Financial Disclosure:


Back to previous